 Biotechnology firm Spectrum Pharmaceuticals NASDAQ: SPPI recently received regulatory approval for its inflation-reducing injections associated with anti-cancer drugs, thus driving SPPI stock significantly higher on Monday morning. According to the companys Sept. 